This study aims to comprehensively identify the various treatment patterns of second- or subsequent-line palliative chemotherapy used in patients with metastatic colorectal cancer who have experienced failure of first-line palliative chemotherapy and to evaluate the prognosis of each treatment.
Patients who have signed the informed consent after receiving information about the purpose and method of this study.
Patients with histologically and radiologically confirmed metastatic colorectal cancer (colorectal cancer) who have evaluable (measurable) lesions.
Patients scheduled to receive their first second-line palliative chemotherapy following failure of first-line palliative chemotherapy (including those who relapse during or within 6 months after completion of postoperative adjuvant therapy, necessitating palliative chemotherapy).
Patients who understand the research, are cooperative in the research process, and are deemed capable of participating until the completion date.
Female patients who are pregnant, have childbearing potential, or are breastfeeding.
Has received an investigational product within 4 weeks from the study enrollment or has plans to participate in another clinical trial during the participation of this study.
Other subjects who are considered inappropriate to participate in this study by the judgment of the investigator.
Patients with metastatic colorectal cancer (colon and rectal cancer) who have failed first-line palliative chemotherapy
Cohort
Prospective
Second and later-line palliative chemotherapy
DrugAs this is a non-interventional study designed to collect data as part of routine clinical practice, the selection and dosage of medication, treatment period, and whether or not to change it are all based on the clinician's judgment
Progression-free survival (PFS)
Progression-free survival (PFS) by treatment pattern
Overall Survival (OS)
Overall Survival (OS) by treatment pattern
Dosage period for each treatment pattern
Objective Response Rate (ORR)
Types of Secondary palliative chemotherapy
Click on the lead sponsor to view all of their trials.
